{
    "xml": "<topic id=\"PHP424\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/sucralfate\" basename=\"sucralfate\" title=\"SUCRALFATE\">\n<title>SUCRALFATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_755\" namespace=\"/interactions/list-of-drug-interactions/ulcer-healing-drugs/sucralfate\">Sucralfate</xref>\n</p>\n<data name=\"vtmid\">69967001</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP39057\" outputclass=\"indicationsAndDose\" rev=\"1.29\" parent=\"/drugs/sucralfate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Benign gastric ulceration</p>\n<p outputclass=\"therapeuticIndication\">Benign duodenal ulceration</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 15&#8211;17 years</p>\n<p>2&#8239;g twice daily, dose to be taken on rising and at bedtime, alternatively 1&#8239;g 4 times a day for 4&#8211;6 weeks, or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8&#8239;g per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;g twice daily, dose to be taken on rising and at bedtime, alternatively 1&#8239;g 4 times a day for 4&#8211;6 weeks, or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Chronic gastritis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;g twice daily, dose to be taken on rising and at bedtime, alternatively 1&#8239;g 4 times a day for 4&#8211;6 weeks or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of stress ulceration in child under intensive care</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 15&#8211;17 years</p>\n<p>1&#8239;g 6 times a day; maximum 8&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of stress ulceration</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g 6 times a day; maximum 8&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39007\" outputclass=\"unlicensedUse\" rev=\"1.10\" parent=\"/drugs/sucralfate\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Not licensed for use in children under 15 years.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Tablets not licensed for prophylaxis of stress ulceration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39106\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/drugs/sucralfate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Patients under intensive care (<b>Important: </b>reports of bezoar formation)</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Bezoar formation</p>\n<p>Following reports of bezoar formation associated with sucralfate, caution is advised in seriously ill patients, especially those receiving concomitant enteral feeds or those with predisposing conditions such as delayed gastric emptying.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39052\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/sucralfate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (sucralfate).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39029\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/sucralfate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Constipation</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Back pain</ph>; <ph outputclass=\"sideEffect\">bezoar formation</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">eadache</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">gastric discomfort</ph>; <ph outputclass=\"sideEffect\">indigestion</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">rash</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39047\" outputclass=\"pregnancy\" parent=\"/drugs/sucralfate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No evidence of harm; absorption from gastro-intestinal tract negligible.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39118\" outputclass=\"breastFeeding\" parent=\"/drugs/sucralfate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Amount probably too small to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39042\" outputclass=\"renalImpairment\" parent=\"/drugs/sucralfate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution; aluminium is absorbed and may accumulate.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39129\" outputclass=\"directionsForAdministration\" rev=\"1.14\" parent=\"/drugs/sucralfate\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Administration of sucralfate and enteral feeds should be separated by 1 hour and for administration by <i>mouth</i>, sucralfate should be given 1 hour before meals.</p>\n<p>\n<i>Oral suspension</i> blocks fine-bore feeding tubes.</p>\n<p>Crushed <i>tablets</i> may be dispersed in water.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58976\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/sucralfate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of oral liquid formulations may include aniseed and caramel.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP424-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/sucralfate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, cream, powder, enema</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78237\" namespace=\"/treatment-summaries/chelates-and-complexes\" title=\"Chelates and complexes\" count=\"1\" rel=\"backlink\">Chelates and complexes</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_755\" namespace=\"/interactions/list-of-drug-interactions/ulcer-healing-drugs/sucralfate\" title=\"Sucralfate\" count=\"1\" rel=\"link\">Sucralfate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n</links>\n</topic>",
    "id": "PHP424",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/sucralfate",
    "basename": "sucralfate",
    "title": "SUCRALFATE",
    "interactants": [
        {
            "id": "bnf_int_755",
            "label": "Sucralfate"
        }
    ],
    "vtmid": "69967001",
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Benign gastric ulceration",
                        "html": "Benign gastric ulceration"
                    },
                    {
                        "textContent": "Benign duodenal ulceration",
                        "html": "Benign duodenal ulceration"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "2 g twice daily, dose to be taken on rising and at bedtime, alternatively 1 g 4 times a day for 4&#8211;6 weeks, or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8 g per day.",
                        "html": "<p>2&#8239;g twice daily, dose to be taken on rising and at bedtime, alternatively 1&#8239;g 4 times a day for 4&#8211;6 weeks, or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8&#8239;g per day.</p>",
                        "ageGroup": "15&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "2 g twice daily, dose to be taken on rising and at bedtime, alternatively 1 g 4 times a day for 4&#8211;6 weeks, or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8 g per day.",
                        "html": "<p>2&#8239;g twice daily, dose to be taken on rising and at bedtime, alternatively 1&#8239;g 4 times a day for 4&#8211;6 weeks, or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8&#8239;g per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Chronic gastritis",
                        "html": "Chronic gastritis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2 g twice daily, dose to be taken on rising and at bedtime, alternatively 1 g 4 times a day for 4&#8211;6 weeks or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8 g per day.",
                        "html": "<p>2&#8239;g twice daily, dose to be taken on rising and at bedtime, alternatively 1&#8239;g 4 times a day for 4&#8211;6 weeks or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8&#8239;g per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of stress ulceration in child under intensive care",
                        "html": "Prophylaxis of stress ulceration in child under intensive care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "1 g 6 times a day; maximum 8 g per day.",
                        "html": "<p>1&#8239;g 6 times a day; maximum 8&#8239;g per day.</p>",
                        "ageGroup": "15&#8211;17 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of stress ulceration",
                        "html": "Prophylaxis of stress ulceration"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 g 6 times a day; maximum 8 g per day.",
                        "html": "<p>1&#8239;g 6 times a day; maximum 8&#8239;g per day.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Not licensed for use in children under 15 years.",
                "html": "<p>Not licensed for use in children under 15 years.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Tablets not licensed for prophylaxis of stress ulceration.",
                "html": "<p>Tablets not licensed for prophylaxis of stress ulceration.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Patients under intensive care (Important: reports of bezoar formation)",
                "html": "Patients under intensive care (<b>Important: </b>reports of bezoar formation)"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Bezoar formation",
                "textContent": "Following reports of bezoar formation associated with sucralfate, caution is advised in seriously ill patients, especially those receiving concomitant enteral feeds or those with predisposing conditions such as delayed gastric emptying.",
                "html": "<p>Following reports of bezoar formation associated with sucralfate, caution is advised in seriously ill patients, especially those receiving concomitant enteral feeds or those with predisposing conditions such as delayed gastric emptying.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (sucralfate).",
                "html": "<p>Appendix 1 (sucralfate).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Constipation",
                        "html": "Constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Back pain",
                        "html": "Back pain",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "bezoar formation",
                        "html": "bezoar formation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "eadache",
                        "html": "eadache",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "gastric discomfort",
                        "html": "gastric discomfort",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "indigestion",
                        "html": "indigestion",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No evidence of harm; absorption from gastro-intestinal tract negligible.",
                "html": "<p>No evidence of harm; absorption from gastro-intestinal tract negligible.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Amount probably too small to be harmful.",
                "html": "<p>Amount probably too small to be harmful.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution; aluminium is absorbed and may accumulate.",
                "html": "<p>Use with caution; aluminium is absorbed and may accumulate.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Administration of sucralfate and enteral feeds should be separated by 1 hour and for administration by mouth, sucralfate should be given 1 hour before meals.\n\nOral suspension blocks fine-bore feeding tubes.\n\nCrushed tablets may be dispersed in water.",
                "html": "<p>Administration of sucralfate and enteral feeds should be separated by 1 hour and for administration by <i>mouth</i>, sucralfate should be given 1 hour before meals.</p><p>\n<i>Oral suspension</i> blocks fine-bore feeding tubes.</p><p>Crushed <i>tablets</i> may be dispersed in water.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of oral liquid formulations may include aniseed and caramel.",
                "html": "<p>Flavours of oral liquid formulations may include aniseed and caramel.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "cream",
                "powder",
                "enema"
            ]
        }
    },
    "backlinks": {
        "treatmentSummary": [
            {
                "id": "PHP78237",
                "label": "Chelates and complexes",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_755",
                "label": "Sucralfate",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ]
    }
}